PATENT CLAIM ANALYSIS

Application Number: 15990030
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "233500"]

Abstract:
The present invention is directed to methods of inhibiting both proliferation and survival of cancer cells and for treating a subject having cancer. The present invention is further directed to methods of diagnosing cancer in a subject and identifying cancer therapeutics.

Claim (Index 13):
The method according to  claim 1 , wherein said administering is carried out ex vivo.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 93.0
- Lexical Diversity: 1.65385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14009013', '13259533', '13873799', '14239503', '15321684']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7437452211878972
- 35 USC 102 Novelty (BERT): 0.5995007743432329
- Combined Prediction Score: 0.7293207765034309
- Mean Citation Score: 270.50412800000004
- Max Citation Score: 537.4201
- Similarity Product: 443.93301382499936

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test